Sustained-release liposomal anesthetic compositions
AssigneeSkyePharma Inc.
InventorsSinil Kim, Taehee Kim, Sharad Murdande
Life of this patent
Estimating the term…
Loading patent…
AssigneeSkyePharma Inc.
InventorsSinil Kim, Taehee Kim, Sharad Murdande
Estimating the term…
The invention provides a method for obtaining local anesthetics encapsulated in liposomes, such as multivesicular liposomes, with high encapsulation efficiency and slow release in vivo. When the encapsulated anesthetic is administered as a single intracutaneous dose, the duration of anesthesia and half-life of the drug at the local injection site is increased as compared to injection of unencapsulated anesthetic. The maximum tolerated dose of the encapsulated anesthetic is also markedly increased in the liposomal formulation over injection of unencapsulated anesthetic. These results show that the liposomal formulation of local anesthetic is useful for sustained local infiltration and nerve block anesthesia.
1-22. (canceled)
A pharmaceutical composition comprising:
The pharmaceutical composition of claim 8, wherein the xylidide has the following structure:
A process for preparing a multivesicular liposome-encapsulated anesthetic composition, the process comprising:
A method of increasing drug loading in a multivesicular liposome by converting an amide anesthetic into a binary salt mixture wherein two counterions are derived from an acid selected from the group consisting of polyhydroxy carboxylic, diprotic mineral, triprotic mineral, and combinations thereof.
Dependencies are inferred from the claim text.